Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.

This article explores multiplexing applications in biopharma and highlights key assay development factors to consider.

Explore how proteomics in biomarker discovery accelerates diagnostic assay development and improves clinical validation.

The single-stranded DNA molecules developed by researchers using the SELEX technology could transform blood testing for Alzheimer's biomarkers. These synthetic aptamers target neurofilament light ...

Explore what is driving progress in neurological biomarker research today, from emerging technologies to clinical translation ...

Geroscience examines the underlying biology of aging to delay chronic diseases and extend the healthy years of human life.

Interim observations from the Phase 2 TRAILHEAD study show continued improvement in handgrip strength, overall stability of elbow and shoulder strength in new dynamometry measurements Greater ...

Panome Bio, a CRO, launched MassID™, a cloud-based computational platform designed to improve how researchers process and interpret untargeted LC/MS metabolomics data. The platform is described in a ...

BALTIMORE, MD, UNITED STATES, March 10, 2026 /EINPresswire.com/ — Scipher Medicine and Senelix today announced a strategic collaboration to incorporate Scipher’s AI network platform to de-risk and ...

ALBANY, N.Y. (NEXSTAR) — The New York State Senate and Assembly released their One-House Budget proposals for the 2027 fiscal year, which starts on April 1, 2026. Advocacy organizations, industry ...

The Global Cardiac Biomarkers Market is driven by the rising prevalence of cardiovascular diseases, demanding rapid, accurate diagnostics. Opportunities lie in technological advancements in biomarker ...

OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced a strategic data licensing agreement with Risorius Co., Ltd., a ...